Former U.S. President Donald Trump has announced plans to impose a sweeping 100% tariff on all branded drug imports starting October 1, unless pharmaceutical companies set up manufacturing facilities within the United States. The move is positioned as an effort to reduce reliance on foreign drug supplies and bring pharmaceutical production back home. Trump criticized “outsourcing of critical healthcare products” and framed the decision as a matter of national security and economic sovereignty.